Evolus (NASDAQ: EOLS) reported Q1 EPS of ($0.22), $0.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $59.3 million versus the consensus estimate of $57.32 million.

GUIDANCE:

Evolus sees FY2024 revenue of $255-265 million, versus the consensus of $262.8 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.